Peter Ferenci

21PUBLICATIONS
59CO-AUTHORS
Gastroenterology and hepatologyMedical molecular engineering of nucleic acids and proteinsMedical ethicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 27, 2024
Portal hypertension and its prognostic implications in patients with Wilson's disease.

Lukas Burghart, Peter Ferenci, Oleksandr Petrenko

|Nov 26, 2022
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update.

Peter Ferenci, Thomas Reiberger, Mathias Jachs

|Jul 09, 2022
Sex Disparities in Outcome of Patients with Alcohol-Related Liver Cirrhosis within the Eurotransplant Network-A Competing Risk Analysis.

Stephan Listabarth, Daniel König, Gabriela Berlakovich

|Jun 29, 2022
Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?

Peter Ferenci, Thomas Reiberger, Vanessa Stadlbauer

|May 06, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.

Mathias Jachs, Caroline Schwarz, Marlene Panzer

|Mar 11, 2022
The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.

David Chromy, David J M Bauer, Benedikt Simbrunner

Pageof 4